Lambda, a COVID-19 'variant of interest,' reported in Houston


Houston Methodist Hospital has confirmed its first case of the Lambda coronavirus variant, the Texas hospital system announced Tuesday.
First detected in Peru in December, Lambda has been designated as "a variant of interest" by the World Health Organization, and shares mutations in common with the Gamma variant, which is dominant in Brazil. While Lambda is the predominant strain in Peru, health officials say the Delta variant is still the primary concern in the U.S.
"There's a lot more evidence that we have that Delta is much more contagious, the viral loads are much higher," Dr. Wesley Long, medical director of Diagnostic Microbiology at Houston Methodist, told ABC News.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There are 185 COVID-19 patients in the Houston Methodist Hospital, as of Monday, and 85 percent have been diagnosed with the Delta variant; a majority are unvaccinated. The hospital system said there is an "alarming spike in the number of COVID-19 cases across the Houston area, with the steepest increase happening over the weekend. The increased hospitalizations add stress to many of our hospitals that are nearing capacity."
The Delta variant, first detected in India in December, has been designated by WHO as a "variant of concern" and accounts for about 83 percent of all sequenced COVID-19 cases in the U.S., Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said on Tuesday. In Texas, 51 percent of the population 12 and older is fully vaccinated.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
One great cookbook: ‘The Woks of Life’
The Week Recommends A family’s opinionated, reliable take on all kinds of Chinese cooking
-
Digital addiction: the compulsion to stay online
In depth What it is and how to stop it
-
Can Trump bully Netanyahu into Gaza peace?
Today's Big Question The Israeli leader was ‘strong-armed’ into new peace deal
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts